Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Latest filing published 05 Oct 2026 for Enliven Therapeutics, Inc., €177k. Read the official filing
Filing timeline
BuySaleJ. Scott Garland
Insider track record
Disclosed buys
0
Disclosed sells
1
Signal history
No signal scores available.
J. Scott Garland: trading record in brief
J. Scott Garland is a declared insider of Enliven Therapeutics, Inc., with filings sourced from SEC (Form 4). The record holds 2 filings, all for trades on 1 October 2026.
No open-market purchase appears, only 1 sale worth €535k. Besides market trades, the filings include 1 option exercise.
The newest entry dates from 5 October 2026: an option exercise of €177k, in Enliven Therapeutics, Inc. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to J. Scott Garland
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
13,000 shares@ US$15.47Common StockSEC:0001533228-26-000009:0
13,000 shares@ US$46.6707Common StockSEC:0001533228-26-000009:1
2 of 2 declarations
